Treatment of osteomyelitis with oral bactericidal antibiotics - Our experience with 9 patients;DIE BEHANDLUNG DER OSTEOMYELITIS MIT PERORALEN BAKTERIZIDEN ANTIBIOTIKA - BESCHREIBUNG VON 9 FALLEN

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 4, 1996, Pages 124-127

  Major, S ^a   Chuard, C ^a   Regamey, C ^a  

^a Hopital Cantonal de Fribourg   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLAVULANIC ACID; COTRIMOXAZOLE; FLUCLOXACILLIN; OFLOXACIN; RIFAMPICIN;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; OSTEOMYELITIS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOMYELITIS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TREATMENT OUTCOME;

EID: 0030024785     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Mandell GL, Bennet JE, Dolin R: Principles und practice of infectious diseases. New York: Churchill Livingstone, 1995.
2. Waldvogel FA, Vasey H: Osteomyelitis: the past decade. N Engl J Med 1980; 303: 360-368.
3. Aronoff SC, Scoles PV, Makley JT, Jacobs MR, Blumer JL et al.: Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children. Rev Infect Dis 1986; 8 (Suppl. 5): S639-S643.
4. Kolyvas E: Oral antibiotic therapy of skeletal infections in children. Pediatrics 1980; 65: 867.
5. Fong IW, Ledbetter WH, Vandenbroucke AC, Simbul M, Rahm V: Ciprofloxacin concentrations in bone and muscle after oral dosing. Antimicrob Agents Chemother 1986; 29: 405-408.
6. Nix DE, Cumbo TJ, Kuritsky P, DeVito JM, Schentag JJ: Oral ciprofloxacin in the treatment of serious soft tissue and bone infection: Efficacy, safety, and pharmacokinetics. Am J Med 1987; 82 (Suppl. 4A): 146-153.
7. Hessen MT, Ingerman MJ, Kaufman DH, Weiner P, Santoro J et al.: Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis. Am J Med 1987; 82 (Suppl. 4A): 262-265.
8. Swedish Study Group: Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. J Antimicrob Chemother 1988; 22: 221-228.
9. Ramirez CA, Bran JL, Mejia CR, Garcia JF: Open, prospective study of the clinical efficacy of ciprofloxacin. Antimicrob Agents Chemother 1985; 28: 128-132.
10. Drancourt M, Stein A, Argenson JN, Zennier A, Curvale G et al.: Oral rifampicin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37: 1214-1218.
11. Yeldandi V, Strodtman R, Lentino JR: In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple-resistant Staphylococcus aureus. J Antimicrob Chemother 1988; 22: 873-880.
12. Gentry LO, Rodriguez-Gomez G: Ofloxacin versus patenteral therapy for chronic osteomyelitis. Antimicrob Agents Chemother 1991; 35: 538-541.
13. Anthony JP, Mathes SJ: Update on chronic osteomyelitis. Clin Plast Surg 1991; 18: 515-523.
14. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests; approved standards. NCCLS document M2-AS. NCCLS, Villanova, Pa, 1993.
15. Schlichter J-G, MacLean H: A method of determining the effective therapeutic level in the treatment of subacute bacterial endocarditis with penicillin. Am Heart J 1947; 34: 209-214.
16. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W: Antimicrobial treatment of orthopedic implant-related infections with rifampicin combinations. Clin Infect Dis 1992; 14: 1251-1253.
17. Chuard C, Herrmann M, Vaudaux P, Waldvogel FA, Lew DP: Successful therapy of experimental chronic foreign body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991; 35: 2611-2616.
18. Schaad HJ, Chuard C, Vaudaux P, Waldvogel FA, Lew DP: Teicoplanin alone or combined with rifampicin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1994; 38: 1703-1710.
19. Cagni AL, Chuard C, Vaudaux P, Schrenzel J, Lew DP: Comparison of sparfloxacin, temafloxacin and ciprofloxacin for prophylaxis and treatment of experimental foreign body infections by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995; 39: 1655-1660.